Wei-Li Wang
Biographic Data
| ID | 7240510 |
|---|---|
| NAME | Wei-Li Wang |
| GIVEN NAMES | Wei-Li |
| FAMILY NAME | Wang |
| SIGNATURE | WANG W |
| AFFILIATIONS | Guiyang Medical University |
| ORCID | 0000-0001-5115-7196 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Global prevalence trends and predictions of Hodgkin lymphoma from 1990 to 2021
Background: Hodgkin lymphoma (HL) is a highly curable malignancy with distinctive aetiological subtypes. Given recent therapeutic advances and demographic changes, an up-to-date assessment of the global HL burden is needed to inform evidence-based resource allocation and health policy planning. This study described the global prevalence trend of HL and analysed its age cohort and transnational inequality. Methods: We used data from the Global Bur…
On practicing magicine, from wonder to care
No prominent works on this page.
On practicing magicine, from wonder to care
Global prevalence trends and predictions of Hodgkin lymphoma from 1990 to 2021
Background: Hodgkin lymphoma (HL) is a highly curable malignancy with distinctive aetiological subtypes. Given recent therapeutic advances and demographic changes, an up-to-date assessment of the global HL burden is needed to inform evidence-based resource allocation and health policy planning. This study described the global prevalence trend of HL and analysed its age cohort and transnational inequality. Methods: We used data from the Global Bur…
Epidemiology (1 work) · Global Cancer Incidence and Screening (1 work) · Global health (1 work) · Health equity (1 work) · Hodgkin lymphoma (1 work) · Inequality (1 work) · Lymphoma Diagnosis and Treatment (1 work) · MEDLINE (1 work) · Multiple and Secondary Primary Cancers (1 work)